Compare MDLN & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDLN | EL |
|---|---|---|
| Founded | 1966 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.4B | 30.9B |
| IPO Year | 2025 | 2007 |
| Metric | MDLN | EL |
|---|---|---|
| Price | $35.45 | $86.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 23 | 20 |
| Target Price | $50.48 | ★ $97.60 |
| AVG Volume (30 Days) | ★ 6.9M | 2.2M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.23 | ★ 0.82 |
| Revenue | ★ $28,432,000,000.00 | $14,326,000,000.00 |
| Revenue This Year | $10.88 | $7.51 |
| Revenue Next Year | $7.69 | $4.08 |
| P/E Ratio | $154.74 | ★ $106.50 |
| Revenue Growth | ★ 11.47 | N/A |
| 52 Week Low | $32.82 | $66.22 |
| 52 Week High | $50.88 | $121.64 |
| Indicator | MDLN | EL |
|---|---|---|
| Relative Strength Index (RSI) | 42.14 | 54.68 |
| Support Level | $34.32 | $84.90 |
| Resistance Level | $37.79 | $88.00 |
| Average True Range (ATR) | 1.62 | 2.37 |
| MACD | -0.39 | 0.22 |
| Stochastic Oscillator | 27.24 | 60.30 |
Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top-selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.